The US is on track to make $300m a day in revenue from drug sales this year from its pharmaceutical manufacturing sector, according to a report from the US Chamber of Commerce.Glenmark Pharmaceuticals, for example, reported that its sales of Pfizer’s cholesterol drug rivastigmine increased by nearly 30 per cent in the first quarter.Inovio Pharmaceuticals […]

Continue Reading...